Acute Decompensated Heart Failure with Severe Left Ventricular Systolic Dysfunction of Undetermined Etiology in a 26-Year-Old Male: A Case Report

Downloads

Authors

  • Abdul Eizad Asif Shalamar Medical and Dental College, Lahore, Pakistan https://orcid.org/0009-0009-7362-0394
    Competing Interests
    The authors have no conflicts of interest to declare.
  • Ahmad Mustafa Butt Central Park Medical College, Lahore, Pakistan https://orcid.org/0009-0001-8639-8501
    Competing Interests
    The authors have no conflicts of interest to declare.
  • Syed Tahir Hussain Central Park Teaching Hospital, Lahore, Pakistan https://orcid.org/0009-0000-7072-0044
    Competing Interests
    The authors have no conflicts of interest to declare.
  • Aqsa Ibrahim Central Park Medical College, Lahore, Pakistan https://orcid.org/0009-0001-6312-0259
    Competing Interests
    The authors have no conflicts of interest to declare.
  • Muhammad Hassaan Javaid Shifa College of Medicine, Islamabad, Pakistan https://orcid.org/0009-0000-1800-1800
    Competing Interests
    The authors have no conflicts of interest to declare.

DOI:

https://doi.org/10.71079/ASIDE.CV.081826789

Abstract

Heart failure with reduced ejection fraction HFrEF is rare in young adults but may develop when multiple uncontrolled cardiovascular risk factors are present. The diagnosis of an underlying cause of heart failure among younger patients is difficult due to multiple possible etiologies of LV systolic dysfunction, which might have similar clinical manifestations and imaging features. A 26-year-old man with a past medical history of uncontrolled hypertension and smoking, who came to hospital with complaints of sudden onset of dyspnea and chest pain on the left side, was investigated further to have sinus tachycardia with abnormal R-wave progression on electrocardiogram, cardiomegaly with pulmonary congestion on chest X-ray, and significantly impaired global systolic function of the left ventricle with ejection fraction of 25% on transthoracic echocardiogram. Troponins showed no dynamic change in their rise-and-fall pattern, ruling out acute coronary syndrome. He was stabilized on CPAP breathing and IV nitroglycerine and loop diuretics, with marked relief in symptoms. Following hemodynamic stabilization, guideline-directed medical therapy for HFrEF was initiated. In this case, there is acute decompensated heart failure with reduced ejection fraction (HFrEF) characterized by severe systolic dysfunction occurring in a relatively young individual suffering from numerous risk factors for cardiovascular disorders. The etiology of the condition could not be precisely determined due to the unavailability of coronary angiography and other advanced diagnostic methods. Ischemic cardiomyopathy is just one of the potential causes that also include hypertensive cardiomyopathy, idiopathic dilated cardiomyopathy, toxic cardiomyopathy, and inflammatory cardiomyopathy. The present report highlights the need for careful etiologic assessment of patients presenting with recently developed ventricular dysfunction, appropriate diagnosis in the absence of evidence of coronary disease, and prompt initiation of appropriate therapy

Keywords:

Heart failure with reduced ejection fraction, Undetermined etiology cardiomyopathy, Ischemic cardiomyopathy, Acute pulmonary edema, Hypertension

Author Biography

  • Abdul Eizad Asif, Shalamar Medical and Dental College, Lahore, Pakistan

    Department of Medicine 

References

1. Savarese G, Lund LH. Global public health burden of heart failure. Card Fail Rev. 2017;3(1):7-11. [PMID: 28785469, https://doi.org/10.15420/cfr.2016:25:2] DOI: https://doi.org/10.15420/cfr.2016:25:2

2. Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics—2023 update: a report from the American Heart Association. Circulation. 2023;147(8):e93-e621. [PMID: 36695182, https://doi.org/10.1161/CIR.0000000000001123] DOI: https://doi.org/10.1161/CIR.0000000000001137

3. McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599-726. [PMID: 34447992, https://doi.org/10.1093/eurheartj/ehab368] DOI: https://doi.org/10.1093/eurheartj/ehab368

4. Felker GM, Shaw LK, O’Connor CM. A standardized definition of ischemic cardiomyopathy for use in clinical research. J Am Coll Cardiol. 2002;39(2):210-8. [PMID: 11788209, https://doi.org/10.1016/s0735-1097(01)01738-7] DOI: https://doi.org/10.1016/S0735-1097(01)01738-7

5. Gheorghiade M, Bonow RO. Chronic heart failure in the United States: a manifestation of coronary artery disease. Circulation. 1998;97(3):282-9. [PMID: 9462531, https://doi.org/10.1161/01.cir.97.3.282] DOI: https://doi.org/10.1161/01.CIR.97.3.282

6. Sharma SK, Makkar JS, Bana A, et al. Premature coronary artery disease, risk factors, clinical presentation, angiography and interventions: hospital-based registry. Indian Heart J. 2022;74(5):391-7. [PMID: 35995321, https://doi.org/10.1016/j.ihj.2022.08.003] DOI: https://doi.org/10.1016/j.ihj.2022.08.003

7. Smith CL, Seigerman M, Adusumalli S, et al. Evolution and outcomes of premature coronary artery disease. Curr Cardiol Rep. 2021;23(4):36. [PMID: 33686513, https://doi.org/10.1007/s11886-021-01457-8] DOI: https://doi.org/10.1007/s11886-021-01457-8

8. Yusuf S, Hawken S, Ounpuu S, INTERHEART Study Investigators, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries: case-control study. Lancet. 2004;364(9438):937-52. [PMID: 15364185, https://doi.org/10.1016/S0140-6736(04)17018-9] DOI: https://doi.org/10.1016/S0140-6736(04)17018-9

9. Gheorghiade M, Pang PS. Acute heart failure syndromes. J Am Coll Cardiol. 2009;53(7):557-73. [PMID: 19215829, https://doi.org/10.1016/j.jacc.2008.10.041] DOI: https://doi.org/10.1016/j.jacc.2008.10.041

10. Milne EN, Pistolesi M, Miniati M, Giuntini C. The radiologic distinction of cardiogenic and noncardiogenic edema. AJR Am J Roentgenol. 1985;144(5):879-94. [PMID: 3872571, https://doi.org/10.2214/ajr.144.5.879] DOI: https://doi.org/10.2214/ajr.144.5.879

11. Lang RM, Bierig M, Devereux RB, American Society of Echocardiography, et al. Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7(2):79-108. [PMID: 16458610, https://doi.org/10.1016/j.euje.2005.12.014] DOI: https://doi.org/10.1016/j.euje.2005.12.014

12. Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure. Circulation. 2017;136(6):e137-61. [PMID: 28455343, https://doi.org/10.1161/CIR.0000000000000509] DOI: https://doi.org/10.1161/CIR.0000000000000509

13. McMurray JJ, Packer M, Desai AS, PARADIGM-HF Investigators, et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371(11):993-1004. [PMID: 25176015, https://doi.org/10.1056/NEJMoa1409077] DOI: https://doi.org/10.1056/NEJMoa1409077

14. Packer M, Anker SD, Butler J, EMPEROR-Reduced Trial Investigators, et al. Cardiovascular and renal outcomes with empagliflozin in heart failure. N Engl J Med. 2020;383(15):1413-24. [PMID: 32865377, https://doi.org/10.1056/NEJMoa2022190] DOI: https://doi.org/10.1056/NEJMoa2022190

Data Availability Statement

Data are available from the corresponding author on request.

Downloads

Share this article

Published

2026-08-18

Issue

Section

Case Report

How to Cite

1.
Asif AE, Butt AM, Hussain ST, Ibrahim A, Javaid MH. Acute Decompensated Heart Failure with Severe Left Ventricular Systolic Dysfunction of Undetermined Etiology in a 26-Year-Old Male: A Case Report. ASIDE Cardiovasc. 2026;1(2):19-25. doi:10.71079/ASIDE.CV.081826789

Article history

Received
23 Apr 2026
Received in revised form
8 Jun 2026
Accepted
30 Jun 2026
Published
18 Aug 2026